BioBanking - The Holy Grail of novel drug and diagnostic developments?
(2011) In Journal of Clinical Bioinformatics 1(1).- Abstract
- ABSTRACT: The ever increasing social cost that society pays for illness and disease are currently steadily increasing in many countries in the world today. These changes in society becomes a major financial burden that activates politicians and health care organizations in order to find new solutions. Biobanks are becoming the new powerful modality within the field of modern Life Science, that is expected to be important in the proactive awareness of patient health status. Biobanks are also expected to promote the developments of targeted treatments with personalized indicator assays, for effective use of Personalized Medicine treatments in the near future.
Please use this url to cite or link to this publication:
https://lup.lub.lu.se/record/2169210
- author
- Marko-Varga, György LU
- organization
- publishing date
- 2011
- type
- Contribution to journal
- publication status
- published
- subject
- in
- Journal of Clinical Bioinformatics
- volume
- 1
- issue
- 1
- article number
- 14
- publisher
- BioMed Central (BMC)
- external identifiers
-
- pmid:21884630
- scopus:84862811277
- pmid:21884630
- ISSN
- 2043-9113
- DOI
- 10.1186/2043-9113-1-14
- language
- English
- LU publication?
- yes
- id
- 52670ad0-834c-487c-8069-404eba576d4b (old id 2169210)
- date added to LUP
- 2016-04-01 13:50:22
- date last changed
- 2022-01-27 21:21:43
@article{52670ad0-834c-487c-8069-404eba576d4b, abstract = {{ABSTRACT: The ever increasing social cost that society pays for illness and disease are currently steadily increasing in many countries in the world today. These changes in society becomes a major financial burden that activates politicians and health care organizations in order to find new solutions. Biobanks are becoming the new powerful modality within the field of modern Life Science, that is expected to be important in the proactive awareness of patient health status. Biobanks are also expected to promote the developments of targeted treatments with personalized indicator assays, for effective use of Personalized Medicine treatments in the near future.}}, author = {{Marko-Varga, György}}, issn = {{2043-9113}}, language = {{eng}}, number = {{1}}, publisher = {{BioMed Central (BMC)}}, series = {{Journal of Clinical Bioinformatics}}, title = {{BioBanking - The Holy Grail of novel drug and diagnostic developments?}}, url = {{http://dx.doi.org/10.1186/2043-9113-1-14}}, doi = {{10.1186/2043-9113-1-14}}, volume = {{1}}, year = {{2011}}, }